Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Hemochromatosis type 4 is a rare form of primary iron overload transmitted as an autosomal dominant trait caused by mutations in the gene encoding the iron transport protein ferroportin 1 (SLC40A1). SLC40A1 mutations fall into two functional categories (loss- versus gain-of-function) underlying two distinct clinical entities (hemochromatosis type 4A versus type 4B). However, the vast majority of SLC40A1 mutations are rare missense variations, with only a few showing strong evidence of causality. The present study reports the results of an integrated approach collecting genetic and phenotypic data from 44 suspected hemochromatosis type 4 patients, with comprehensive structural and functional annotations. Causality was demonstrated for 10 missense variants, showing a clear dichotomy between the two hemochromatosis type 4 subtypes. Two subgroups of loss-of-function mutations were distinguished: one impairing cell-surface expression and one altering only iron egress. Additionally, a new gain-of-function mutation was identified, and the degradation of ferroportin on hepcidin binding was shown to probably depend on the integrity of a large extracellular loop outside of the hepcidin-binding domain. Eight further missense variations, on the other hand, were shown to have no discernible effects at either protein or RNA level; these were found in apparently isolated patients and were associated with a less severe phenotype. The present findings illustrate the importance of combining in silico and biochemical approaches to fully distinguish pathogenic SLC40A1 mutations from benign variants. This has profound implications for patient management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 1×
“SLC40A1 is predominantly regulated by the liver-derived peptide hepcidin, which binds SLC40A1 on the cell surface and induces internalization and degradation (6).”
BackgroundThe iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · cited 1×
“SLC40A1, also known as ferroportin 1 or FPN1 (Uni-Prot #Q9NP59), is the sole iron export protein reported in mammals and is expressed in all types of cell that handle major iron flow, including iron-recycling macrophages, iron-storing hepatocytes and absorptive enterocytes (5).”
BackgroundHereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
Drakesmith, H., Schimanski, L. M., Ormerod, E., Merryweather-Clarke, A. T., Viprakasit, V., Edwards, J. P., Sweetland, E., Bastin, J. M., Cowley, D., Chinthammitr, Y., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0561 · Cited by 264 · cited 2×
“Consistently with both the present observations and previous in vitro findings (18, 29, 38, 39), it has been suggested that the p.”
ResultPreza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234 · cited 3×
“(22, 24), which is consistent with the hepcidin resistance”
BackgroundThe molecular basis of ferroportin-linked hemochromatosis
De Domenico, I., Ward, D. M., Nemeth, E., Vaughn, M. B., Musci, G., Ganz, T., & Kaplan, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503804102 · Cited by 230
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations
Schimanski, L. M., Drakesmith, H., Merryweather-Clarke, A. T., Viprakasit, V., Edwards, J. P., Sweetland, E., Bastin, J. M., Cowley, D., Chinthammitr, Y., Robson, K. J. H., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4502 · Cited by 212
Gordeuk, V. R., Caleffi, A., Corradini, E., Ferrara, F., Jones, R. A., Castro, O., Onyekwere, O., Kittles, R., Pignatti, E., Montosi, G., et al. (2003) · Blood Cells, Molecules, and Diseases · doi:10.1016/s1079-9796(03)00164-5 · Cited by 198
The Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders
Ganz, T., & Nemeth, E. (2011) · Hematology · doi:10.1182/asheducation-2011.1.538 · Cited by 172
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings
Mayr, R., Janecke, A. R., Schranz, M., Griffiths, W. J. H., Vogel, W., Pietrangelo, A., & Zoller, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.016 · Cited by 133 · cited 3×
“To fully understand the allelic heterogeneity found at the SLC40A1 locus, it is noteworthy that few variations have been identified in multiple pedigrees worldwide (1, 12, 13), indicating that only private or population-specific variants contribute to disease .”
Background
Research works printed but not linked: 27
- 2011, Gastroenterology, 140, 1199, 10.1053/j.gastro.2010.12.049 · DOI
- Pelucchi, 2008, Clinical genetics, 73, 171, 10.1111/j.1399-0004.2007.00950.x · DOI · Paper page
- Pietrangelo, 2004, Blood cells, molecules & diseases, 32, 131, 10.1016/j.bcmd.2003.08.003 · DOI · Paper page
- 2011, Journal of hepatology, 54, 173
- 2013, HEMATOL AM SOC HEMATOL EDUC PROGRAM, 2013, 1, 10.1182/asheducation-2013.1.1 · DOI · Paper page
- 2013, Human mutation, 34, 1529, 10.1002/humu.22396 · DOI · Paper page
- Le Gac, 2005, European journal of human genetics : EJHG, 13, 1172, 10.1038/sj.ejhg.5201490 · DOI
- 2013, Human mutation, 34, 1371, 10.1002/humu.22369 · DOI · Paper page
- Goncalves, 2006, Biochemical Journal, 396, 265, 10.1042/BJ20051682 · DOI · Paper page
- Rice, 2009, Journal of molecular biology, 386, 717, 10.1016/j.jmb.2008.12.063 · DOI · Paper page
- 2010, American Journal of Physiology - Cell Physiology, 298, 75
- Corradini, 2007, Gut, 56, 1030, 10.1136/gut.2007.122549 · DOI · Paper page
- 2008, GASTROENTEROLOGIE CLIN BIOL, 32, 321, 10.1016/j.gcb.2008.01.030 · DOI
- 2009, Blood, 114, 437, 10.1182/blood-2008-03-146134 · DOI · Paper page
- 2013, PNAS, 110, 14664, 10.1073/pnas.1308127110 · DOI · Paper page
- De Domenico, 2006, Haematologica, 91, 1092
- Girelli, 2008, Journal of hepatology, 49, 664, 10.1016/j.jhep.2008.05.028 · DOI · Paper page
- 2007, Clinical Chemistry, 53, 2060, 10.1373/clinchem.2007.090605 · DOI · Paper page
- De Domenico, 2008, 8, 146, 10.1016/j.cmet.2008.07.002 · DOI · Paper page
- 2011, Journal of hepatology, 55, 453, 10.1016/j.jhep.2011.02.010 · DOI
- 2009, Haematologica, 94, 335, 10.3324/haematol.2008.000125 · DOI · Paper page
- Barton, 2007, Blood cells, molecules & diseases, 39, 206, 10.1016/j.bcmd.2007.03.008 · DOI
- Beutler, 2003, Blood cells, molecules & diseases, 31, 305, 10.1016/S1079-9796(03)00165-7 · DOI
- McNamara, 2005, Journal of gastroenterology and hepatology, 20, 1855, 10.1111/j.1440-1746.2005.03930.x · DOI · Paper page
- Rivers, 2007, Blood cells, molecules & diseases, 38, 247, 10.1016/j.bcmd.2006.12.002 · DOI
- McGregor, 2005, The Journal of membrane biology, 206, 3, 10.1007/s00232-005-0768-1 · DOI · Paper page
- 2013, Haematologica, 98, 455, 10.3324/haematol.2012.066530 · DOI · Paper page
Cited by
Drakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.006 · Cited by 638
Mechanistic and regulatory aspects of intestinal iron absorption
Gulec, S., Anderson, G. J., & Collins, J. F. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2013 · Cited by 406
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
Billesbølle, C. B., Azumaya, C. M., Kretsch, R. C., Powers, A. S., Gonen, S., Schneider, S., Arvedson, T., Dror, R. O., Cheng, Y., & Manglik, A. (2020) · Nature · doi:10.1038/s41586-020-2668-z · Cited by 344
Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325
Ferroportin disease: pathogenesis, diagnosis and treatment
Pietrangelo, A. (2017) · Haematologica · doi:10.3324/haematol.2017.170720 · Cited by 151
Metadata
- Authors
- Callebaut, I., Joubrel, R., Pissard, S., Kannengiesser, C., Gerolami, V., Ged, C., Cadet, E., Cartault, F., Ka, C., Gourlaouen, I., Gourhant, L., Oudin, C., Goossens, M., Grandchamp, B., De Verneuil, H., Rochette, J., Ferec, C., & Le Gac, G.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-08
- Volume
- 23
- Issue
- 17
- Pages
- 4479-4490
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2144755145
- Cited by
- 54
- References
- 11
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients. https://app.cochat.ai/papers/10.1093/hmg/ddu160
- The paper
- Callebaut, I., Joubrel, R., Pissard, S., Kannengiesser, C., Gerolami, V., Ged, C., Cadet, E., Cartault, F., Ka, C., Gourlaouen, I., Gourhant, L., Oudin, C., Goossens, M., Grandchamp, B., De Verneuil, H., Rochette, J., Ferec, C., & Le Gac, G. (2014). Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddu160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.